Literature DB >> 10518579

Selective expression of the large neutral amino acid transporter at the blood-brain barrier.

R J Boado1, J Y Li, M Nagaya, C Zhang, W M Pardridge.   

Abstract

Amino acid supply in brain is regulated by the activity of the large neutral amino acid transporter (LAT) at the brain capillary endothelial cell, which forms the blood-brain barrier (BBB) in vivo. Bovine BBB poly(A)(+) RNA was isolated from 2.0 kg of fresh bovine brain and size fractionated on a sucrose density gradient, and a size-fractionated bovine BBB cDNA library in the pSPORT vector was prepared. The full-length cDNA encoding the bovine BBB LAT was isolated from this library, and the predicted amino acid sequence was 89-92% identical to the LAT1 isoform. The bovine BBB LAT1 mRNA produced a 10-fold enhancement in tryptophan transport into frog oocytes coinjected with bovine BBB LAT1 mRNA and the mRNA for 4F2hc, which encodes the heavy chain of the heterodimer. Tryptophan transport into the mRNA-injected oocytes was sodium independent and was specifically inhibited by other large neutral amino acids, and the K(m) of tryptophan transport was 31.5 +/- 5.5 microM. Northern blotting with the bovine BBB LAT1 cDNA showed that the LAT1 mRNA is 100-fold higher in isolated bovine brain capillaries compared with C6 rat glioma cells or rat brain, and the LAT1 mRNA was not detected in rat liver, heart, lung, or kidney. These studies show that the LAT1 transcript is selectively expressed at the BBB compared with other tissues, and the abundance of the LAT1 mRNA at the BBB is manyfold higher than that of transcripts such as the 4F2hc antigen, actin, or the Glut1 glucose transporter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518579      PMCID: PMC18415          DOI: 10.1073/pnas.96.21.12079

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.

Authors:  W M Pardridge; R J Boado; C R Farrell
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

2.  The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier.

Authors:  R J Boado; W M Pardridge
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

3.  Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5'-untranslated region.

Authors:  R J Boado; W M Pardridge
Journal:  Mol Cell Neurosci       Date:  1990-12       Impact factor: 4.314

4.  Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.

Authors:  H Segawa; Y Fukasawa; K Miyamoto; E Takeda; H Endou; Y Kanai
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

5.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

6.  Kinetic constants for blood-brain barrier amino acid transport in conscious rats.

Authors:  L P Miller; W M Pardridge; L D Braun; W H Oldendorf
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

7.  Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function.

Authors:  P D Prasad; H Wang; W Huang; R Kekuda; D P Rajan; F H Leibach; V Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  1999-02-16       Impact factor: 3.575

8.  Evidence for translational control elements within the 5'-untranslated region of GLUT1 glucose transporter mRNA.

Authors:  R J Boado; H Tsukamoto; W M Pardridge
Journal:  J Neurochem       Date:  1996-10       Impact factor: 5.372

9.  TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation.

Authors:  J Sang; Y P Lim; M Panzica; P Finch; N L Thompson
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

Review 10.  Gene-product designations for amino acid transporters.

Authors:  H N Christensen; L M Albritton; D K Kakuda; C L MacLeod
Journal:  J Exp Biol       Date:  1994-11       Impact factor: 3.312

View more
  119 in total

1.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates.

Authors:  Christian Meier; Zorica Ristic; Stefan Klauser; François Verrey
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 2.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

Review 3.  Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.

Authors:  Akira Tsuji
Journal:  NeuroRx       Date:  2005-01

Review 4.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 5.  Molecular biology of the blood-brain barrier.

Authors:  William M Pardridge
Journal:  Mol Biotechnol       Date:  2005-05       Impact factor: 2.695

Review 6.  Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.

Authors:  Françoise Roux; Pierre-Olivier Couraud
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

7.  Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries.

Authors:  Kazuhisa Sakai; Hidemi Shimizu; Tatsuro Koike; Shigeki Furuya; Masahiko Watanabe
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

8.  Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3'-triiodo-L-thyronine.

Authors:  Ainhoa Ceballos; Monica M Belinchon; Eduardo Sanchez-Mendoza; Carmen Grijota-Martinez; Alexandra M Dumitrescu; Samuel Refetoff; Beatriz Morte; Juan Bernal
Journal:  Endocrinology       Date:  2009-01-15       Impact factor: 4.736

9.  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.

Authors:  Arik A Zur; Huan-Chieh Chien; Evan Augustyn; Andrew Flint; Nathan Heeren; Karissa Finke; Christopher Hernandez; Logan Hansen; Sydney Miller; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-09-03       Impact factor: 2.823

10.  An improved zebrafish transcriptome annotation for sensitive and comprehensive detection of cell type-specific genes.

Authors:  Nathan D Lawson; Rui Li; Masahiro Shin; Ann Grosse; Onur Yukselen; Oliver A Stone; Alper Kucukural; Lihua Zhu
Journal:  Elife       Date:  2020-08-24       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.